The Future of Home Health Care in Clinical Trials
In a post-pandemic society, sponsors and research institutions have adapted to new ways of working, particularly in the conduct of clinical trials.
Date: May 22, 2024
Time: 12:00 – 1:00 PM ET
An outcome of the pandemic was a renewed focus on patient-centric approaches to clinical trial success. One of those approaches includes the option of home health components to provide patients more flexibility and reduce participation burden. In this session the speaker will provide insights into their experience with home health visits to-date and hope to engage site and investigator attendees to understand what works and doesn’t work for sites when offered home health options in trial protocols.
Speakers:
Karolyn McKelvey
Associate Director, Relationship Manager
Headquarters Operations, Relationship Management
Merck
Karolyn is an Associate Director in Merck’s Global Clinical Trial Operations group, serving as a Relationship Manager. She brings 30+ years of experience in the pharmaceutical industry supporting clinical trials, most of which has been spent at Merck. In her current role, Karolyn manages Merck partnerships with suppliers in the home healthcare, IRT and adjudication categories. Karolyn holds bachelor’s and master’s degrees, along with a Merck Six Sigma Black Belt certification.
Diana Francisco
Associate Director, Lead Study Manager
Clinical Sciences and Study Management (CSSM) – Oncology | Lung Global Clinical Trial Operations (GCTO)
Merck Research Laboratories
Diana Francisco is an Associate Director in Merck’s Global Clinical Trial Operations. She serves a Lead Study Manager and has lead various Lung Oncology Trial within Merck’s Clinical Sciences and Study Management. She has worked in clinical research for 15+ years in roles raging in Vendor Project Management and Clinical Study Management. Diana holds a Bachelor’s Degree in Biology.
Approved for 1.0 ACRP Contact Hours